Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.7 (
acetylcholinesterase
)
28,390
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Ligatin, a lectin that recognizes phosphorylated sugars, has been demonstrated in mammalian tissues to bind specific hydrolases to cell surfaces. Ligatin exists as a filament that can be released from membranes still complexed with its bound hydrolases by treatment of membrane preparations with CaCl2 and/or pH 8.0. The
ligatin
-hydrolase complexes subsequently can be dissociated with ethyleneglycol-bis(beta-amino-ethyl ether) N, N'-tetraacetic acid, resulting in a concurrent depolymerization of the
ligatin
filament. From membrane preparations of cerebrum, this procedure solubilized
ligatin
and a membrane-bound
acetylcholinesterase
(
EC 3.1.1.7
). Binding of the cosolubilized
acetylcholinesterase
to
ligatin
could be demonstrated in vivo by affinity chromatography using the immobilized lectin. Ligatin-hydrolase complexes have been shown to be dissociated by specific phosphorylated sugars (mannose 6-phosphate and glucose 1-phosphate). These sugars were also effective in eluting bound brain
acetylcholinesterase
from
ligatin
affinity columns. Analysis of labeled glycitols produced by tritiated borohydride reduction confirmed the presence of phosphorylated sugars on the
ligatin
-cosolubilized material from brain.
...
PMID:Brain ligatin: a membrane lectin that binds acetylcholinesterase. 708 78